Summary & Overview
CPT 57291: Construction of Artificial Vagina without Graft
CPT code 57291 represents vaginoplasty creating an artificial vagina without use of a graft to treat congenital absence of a vagina or vaginal agenesis. The code describes a reconstructive gynecologic procedure performed when native vaginal tissue is absent. Nationally, the code is relevant to specialty surgical practices, hospital surgical departments, and ambulatory surgical centers that provide gender-affirming or congenital anomaly reconstructive services.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and the payer mix noted above. The publication provides billing benchmarks, common modifier usage, and coding relationships relevant to surgical and facility billing workflows. It also outlines policy and coverage considerations that influence authorization and reimbursement practices across major national payers.
This summary is intended to orient clinicians, coding professionals, and policy analysts to the clinical purpose of CPT code 57291, the typical care settings, and the areas of payer policy and billing practice that most commonly affect its use.
Billing Code Overview
CPT code 57291 describes a surgical procedure to construct an artificial vagina without use of a graft for patients with congenital absence of a vagina or vaginal agenesis. The procedure is a form of vaginoplasty performed to create a functional vaginal canal when the native anatomy is absent.
-
Service type: Reconstructive gynecologic surgery
-
Typical site of service: Hospital operating room or ambulatory surgical center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adolescent or young adult assigned female at birth presenting with primary amenorrhea, cyclic pelvic pain, or difficulty with intercourse, and is diagnosed with vaginal agenesis or Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. After multidisciplinary evaluation including gynecology, reproductive endocrinology, and counseling, the patient elects surgical creation of a neovagina when non-surgical dilation has failed or is not feasible. Preoperative workup includes pelvic imaging (MRI or ultrasound) to define anatomy, assessment for renal or skeletal anomalies, laboratory studies, and informed consent addressing fertility and sexual function.
The procedure 57291 is performed in an operating room under general anesthesia by a gynecologic surgeon or pediatric/adolescent gynecologic specialist. Intraoperative steps typically include dissection to create a vaginal canal between the rectum and bladder, creation of a mucosal-lined neovaginal cavity without use of grafts, hemostasis, and placement of stent or dilator. Postoperative care involves inpatient or ambulatory recovery, pain control, prophylactic antibiotics if indicated, instructions for dilation schedule, wound and stent care, and outpatient follow-up with the surgical team and pelvic rehabilitation as needed.
Common clinical documentation elements include indications (congenital absence of vagina), preoperative imaging and exam findings, informed consent, operative report describing technique and absence of graft use, estimated blood loss, any intraoperative complications, and postoperative dilation plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|